# Allosteric Bioscience, Inc. — Form D

Allosteric Bioscience, Inc. of New York, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-12-15. The offering totals $3.0M, of which $920K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2021-12-15
- Form: D
- Accession: 0001477932-21-009274
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $920K
- Remaining: $2.1M
- Minimum investment: $5K
- Investors: 14
- Date of first sale: 2021-12-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-425080

## Issuer

- Name: Allosteric Bioscience, Inc.
- CIK: 0001873155
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 315 East 86th Street - 17GE, New York, NY, 10028
- Phone: 646-391-7957

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Bruce Meyers | Director | New York, NY |
| Bruce Meyers | Executive Officer | New York, NY |
| Bruce Meyers | Promoter | New York, NY |

## More

- [CIK 1873155 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1873155&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001477932-21-009274.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.